-
Devices & Diagnostics, MedCity Influencers
Former Medtronic CEO William Hawkins reflects on MDT
They gave him a sword and he handed them the world. When William Hawkins officially […]
-
Devices & Diagnostics, MedCity Influencers, Policy
Committee urges investigation into security of wireless medical devices
The recent report of a computer security expert who hacked his own insulin pump got […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Devices & Diagnostics, MedCity Influencers
Mobile medical apps to be topic of FDA workshop on agency’s guidance
The FDA planned a public workshop for mid-September to discuss the recently released draft guidance […]
-
Devices & Diagnostics, MedCity Influencers
Jacksonville offers $1.6M in aid for Medtronic to create jobs in Florida
Medtronic Inc. (NYSE:MDT) landed a $1.6 million aid package from the Jacksonville City Council, which […]
-
Devices & Diagnostics, MedCity Influencers, Policy
FDA tells ‘fallen angel’ medical devices to submit PMAs or be taken off market
The FDA set an August 23 date for a final rule for three “fallen angel” […]
-
Devices & Diagnostics, MedCity Influencers
BSX’s one-time largest shareholder Paulson & Co. sells all $15M in shares
Paulson & Co. Inc. is Boston Scientific Corp.’s (NYSE:BSX) largest shareholder no more, after liquidating […]
-
Devices & Diagnostics, MedCity Influencers
Japanese trial for Abbott dissolvable stent gets first patient
Abbott (NYSE:ABT) enrolled its first patients in a Japanese trial of the Absorb bioresorbable vascular […]
-
Devices & Diagnostics, MedCity Influencers
Cardiac rhythm management industry still in a slump
The cardiac rhythm management industry looks like it needs of a jolt of its own, […]
-
Devices & Diagnostics, MedCity Influencers
Benefit-risk determination for premarket applications outlined by FDA
The FDA released a new guidance yesterday detailing the agency’s process of making benefit-risk determinations […]
-
Improving Communication Between Patients and Providers
Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works.
-
Devices & Diagnostics, MedCity Influencers
FDA guidance on clinical trials aims to help device makers
The FDA took bold steps to outline expectations for medical device premarket submissions in the […]
-
Devices & Diagnostics, MedCity Influencers
Incontinence device from Medtronic tests well in clinical trials
Medtronic Inc. (NYSE:MDT) got a thumbs up for its InterStim sacral nerve stimulation product’s clinical […]
-
Devices & Diagnostics, MedCity Influencers
FDA’s 510(k) program unfixable, New England Journal of Medicine agrees
The Institute of Medicine was right to dub the FDA’s 510(k) medical device program unfixable, […]
-
US healthcare reform wins one, loses one
In the latest volley in the individual insurance mandate lawsuits, a Ninth Circuit court dismissed […]
-
Devices & Diagnostics, MedCity Influencers
Boston Scientific takes a beating amid stock market chaos
Shares of Boston Scientific Corp. (NYSE:BSX) traded at unusually high volumes for two straight weeks […]
-
Devices & Diagnostics, MedCity Influencers
Diabetes, obesity device company GI Dynamics opens Australian IPO
GI Dynamics officials are still on the down low about their IPO down under, but […]